Toronto, ON – MDS, which services the global life sciences markets, says it has completed an acquisition of Molecular Devices, a Sunnyvale, CA-based developer and supplier of bioanalytical measurement systems whose include instrumentation, software and reagent systems.
MDS says it immediately plans to launch a new business unit called MDS Analytical Technologies, which will combine the Molecular Devices and MDS Sciex businesses. MDS Sciex president, Andy Boorn, PhD will lead the new unit and will launch integration plans immediately to bring together two businesses that had revenues of approximately US$432 million in 2006, and more than 1,100 employees with over 250 scientists and engineers.
“We are very excited by the potential of this winning combination,” says Dr Boorn. “This new business unit will build upon MDS Sciex’s leadership in mass spectrometry and Molecular Devices’ leadership as a renowned supplier of systems, reagents and software used by researchers worldwide to accelerate the pace of drug discovery and development.”